Quick Answer: Use HSA’s current submission guidance to establish notification scope, prepare the local entity, Corppass and CRIS access, and submit through PRISM. Receive the acknowledgement before applicable supply; track the one-year validity and re-notify for continued marketing. Review changes against the permitted amendment rules. Notification is not product approval.
Define the notification record before opening PRISM
A Singapore HSA cosmetic notification is a specific market record, not a general certificate for a factory or brand. Begin by defining the company supplying the product and the exact product identity. Write down the brand, product name, type and planned variants using the same controlled terminology as the artwork and internal product master. This first step prevents a hurried submission from creating a record that is difficult to reconcile with the item actually supplied.
The official HSA submission guidance explains who must notify and the situations outside notification scope. Manufacturers and importers must consider their own obligations even if another company has notified a product from the same manufacturer. Map the actual supply arrangement rather than assuming that a supplier’s existing acknowledgement covers your company. If a scenario is uncertain, resolve it with the local responsible team before supplying the product.
| Scenario | HSA scope point | Practical record |
|---|---|---|
| Different shades or scents | Different variants require notification | Variant register tied to each commercial item |
| Different pack sizes of the same product | Separate notification is not required for pack size alone | Pack-size mapping to the same product identity |
| Another company notified the same manufacturer’s product | Your importing company still needs to consider its own notification | Company and supply-chain responsibility record |
| Sole promotional samples or qualifying research use | Specified exemptions may apply; other requirements remain | Document the actual purpose and restriction of supply |
Separate technical readiness from the transaction
The notification transaction should follow a product review. Assemble the final composition, label, intended use and supporting safety and quality evidence before submission. A successfully completed online form cannot resolve a prohibited ingredient, an unsupported claim or a mismatch between artwork and product identity. Use an issue log with an owner and a closure record for each technical question.
The HSA overview provides the regulatory and label context. Keep the official requirements available during artwork review rather than working from memory. The label designer, regulatory reviewer and manufacturer should be reviewing the same formula and packaging revision. If they are not, stop the handoff long enough to reconcile the records. That small discipline prevents a notification file from becoming detached from production.
Establish local entity and authorised account access
HSA describes a sequence of local entity registration, Corppass registration and CRIS registration before the cosmetic notification submission. The current PRISM service page identifies the CRIS company account and Corppass credentials used for access. Confirm which employee or authorised representative can submit and which person can maintain the record later.
Create an access handover record without circulating passwords in product spreadsheets. Include the company identity, account administrator, authorised submitter, business contact address and backup owner. Test the relevant service access early enough to resolve permission problems before the planned supply date. Account setup is an operational dependency, so give it an explicit owner alongside formula and artwork review.
Agree how an outsourced reviewer works with the local company. A consultant may prepare the data, but the company still needs a reliable record of what was submitted and who can respond when information changes. Store the approved submission dataset and acknowledgement in a location accessible to authorised successors. Avoid making continued compliance depend on one individual’s inbox or a distributor’s informal assurance.
| Record | Manufacturer provides | Brand or local company controls |
|---|---|---|
| Product identity | Accurate product and manufacturer information | Names, type and variants match the offer |
| Technical support | Formula, specifications and available safety evidence | Review closure and access to requested information |
| Submission | Clarification of manufacturing data | Authorised account, final declarations and acknowledgement |
| Maintenance | Advance notice of relevant changes | Validity diary, amendment assessment and cancellation decisions |
Prepare and check the submission dataset
Use the live PRISM service and HSA’s linked procedural guide to prepare the actual fields and presentation types. Do not invent a substitute form from a historic screenshot. Build a submission worksheet that records the final values, the source of each value and the reviewer. This makes the data check repeatable even if the person entering the information did not develop the product.
Compare names character by character where a difference could create confusion. Reconcile manufacturer details with the controlled supplier record and distinguish an office contact from the manufacturing information requested by the service. Check variant names against stock codes, approved artwork and the planned listings. Resolve inconsistent abbreviations before submitting rather than leaving customer service or a future account holder to guess which record applies.
Record the payment result and transaction reference with the notification record. Check the current HSA fees page for the applicable product category and variant treatment when budgeting. The same published fee schedule applies to notification and re-notification. Use the current schedule at the time of the transaction; do not confuse a turnaround entry for a different service with a promise about cosmetic notification processing.
Check acknowledgement before releasing supply
HSA states that an acknowledgement is generated on successful submission and permits sale upon receipt of that acknowledgement. Save the acknowledgement and reconcile it with the intended product and company record. An incomplete draft, an attempted payment or an internal spreadsheet is not the same evidence as the completed transaction. Give the release team a clear way to confirm the correct record before the product becomes available.
The acknowledgement is not an endorsement or certification of product safety and quality. Do not describe the cosmetic as HSA approved in the catalogue, sales pitch or pack. Instead, keep factual regulatory records separate from marketing claims and ensure the finished product continues to meet the applicable requirements. Our ASEAN notification overview explains why national notification and product responsibility remain distinct.
| Stage | Action | Evidence retained |
|---|---|---|
| Before entry | Close product review and verify account access | Approved dataset and responsibility record |
| Submission | Use the official transaction and check completion | Submission reference and acknowledgement |
| Before supply | Match the record to the finished product | Release check linked to product revision |
| During validity | Monitor changes and plan continued marketing | Change log and validity diary |
| End or renewal | Re-notify or cancel as appropriate | New acknowledgement or cancellation record |
Review changes before treating them as amendments
The HSA amendment guidance distinguishes permitted administrative updates from changes requiring cancellation and a new notification. Company name or address changes have specified conditions, including an unchanged UEN and distribution rights. Applicant details and manufacturer details have designated update routes. Confirm the exact transaction and conditions on the current guidance page.
Brand name, product name, product type and a company change of distribution rights are not ordinary amendments under that guidance. HSA directs cancellation and a new notification for those changes. Make this distinction part of launch planning: a late rebrand or distributor change can affect the regulatory record as well as artwork and contracts. Keep the earlier identity linked to its supplied batches so an enquiry can still be traced.
For a formula or other change not resolved by the short administrative list, do not infer permission to amend from silence. Assess the changed product against current technical requirements and confirm the appropriate notification action with the responsible local reviewer or HSA. Document the question, the answer relied on and the product revisions affected. The ingredient review guide provides a useful technical starting point for changed composition.
Plan annual re-notification and post-market follow-up
Each notification is valid for one year, and continued marketing requires annual re-notification under HSA’s current guidance. Build a diary around the actual record rather than assuming all products share the same anniversary. Assign an owner and a backup, review whether each product will continue, and reconcile the data before completing the next transaction. Set internal reminders early enough to resolve access or product questions without relying on a last-minute login.
HSA also describes duties after notification, including supply records, providing requested safety and technical information, and follow-up for adverse events and recalls. Maintain a practical route from customer service and distributors to the local company and manufacturer. A record that cannot be located during an enquiry is operationally weak even if the original transaction was correct.
When a product will no longer be sold, review HSA’s cancellation guidance and keep the decision with the notification history. Reconcile remaining stock and commercial commitments before changing the record. For manufacturing support, share the controlled product brief and open technical questions with your OEM/ODM partner, or contact the team to organise the evidence handoff. The local company should retain ownership of the Singapore compliance decisions.
Keep Singapore procedures distinct from regional and supplier records
| Jurisdiction or record | What to check | Limit of that evidence |
|---|---|---|
| Singapore | HSA requirements and the local company’s applicable notification | Applies to the Singapore supply arrangement and identified product |
| ASEAN regional framework | Technical principles alongside Singapore implementation | Does not create one notification accepted as a national filing everywhere |
| Country of manufacture | Supplier identity, production and export documents relevant to the project | Factory or export records do not replace Singapore market obligations |
Frequently asked questions
Does one notification cover every importer?
No. HSA says notification is required even when another Singapore company has notified the product and it comes from the same manufacturer. Check the obligations of the actual supplying company.
Do different pack sizes need separate notifications?
HSA excludes different pack sizes of the same product from separate notification. Keep clear pack-size mapping and verify that the product itself is unchanged.
How long is a notification valid?
HSA specifies one year. Continued marketing requires re-notification each year, so track the individual record and current transaction requirements.
Can a brand name change be amended?
HSA lists brand name among changes that cannot be amended; its guidance directs cancellation and a new notification. Review the consequences before implementing the new identity.
Is the acknowledgement a safety approval?
No. HSA does not evaluate or approve the cosmetic for supply through this notification. The company remains responsible for product safety, quality and compliance.
Last reviewed: 21 October 2026. General planning information only; this is not product-specific legal or safety advice. Confirm current official requirements and the appropriate action for your product with a qualified local reviewer before manufacture, notification, import or sale.